Certificates of Analysis
Every peptide compound in our catalogue is supplied with a Certificate of Analysis (CoA) confirming its identity, purity, and composition prior to dispatch. CoAs are produced by independent analytical laboratories and are available directly from each product page.
We do not rely solely on manufacturer-issued documentation. Where independent third-party CoAs are available, these are preferred and displayed on the product listing.
Depending on the product and batch, a CoA may include:
HPLC is a chromatographic technique that separates the components of a sample and measures their relative concentrations. For peptides, it provides an accurate measure of compound purity — expressed as a percentage of the total sample area. A result of ≥99% purity means that 99% or more of the detectable material is the target compound.
All single-compound products in our catalogue meet a minimum verified purity of ≥99% by HPLC unless otherwise stated on the product page.
Multi-compound blends — such as our BPC-157 / TB-500 blend and KLOW — are not supplied with an overall HPLC purity figure. Standard HPLC measures purity by separating compounds as they pass through a column at different rates. When multiple peptides are present in a single sample, compounds can co-elute — emerging at similar times — making it impossible to assign a single meaningful purity percentage to the blend as a whole.
This is standard practice across the peptide supply industry. Blended products are supplied with documentation confirming compound identity and composition, but without a combined HPLC purity figure. This reflects the analytical limitations of applying single-method HPLC to multi-compound formulations, not a limitation of the compounds themselves.
Testing documentation is provided to support legitimate in-vitro laboratory research only. CoAs confirm analytical results at the time of testing and do not indicate suitability for human consumption, veterinary use, therapeutic use, diagnostic use, or any clinical application.